MenuМеню
  • Home
  • About Us
  • Medicines
  • Partnering
  • Professionals
  • Responsibility
  • News & Media
  • Careers
  • Investors
  • English
  • Bulgarian

News and Media

  • Financial News
  • News
  • Opinion Pieces
  • Press Releases
  • February 23, 2021

    Bulgaria’s Tchaikapharma gets shareholders nod for 14 mln euro loan for new plant

    SOFIA (Bulgaria), February 23 (SeeNews) – Bulgarian drug maker Tchaikapharma High Quality Medicines [BUL:7TH] said that its shareholders have approved its plan to borrow up to 14 million euro ($17.2 million) in order to finance the construction of a new production plant just outside Sofia.   The proposal was supported by all shareholders present at […]

  • February 3, 2021

    A company of over one billion leva market capitalization on the BSE

    At the beginning of February, one share of the company costs BGN 13.80, which means that the market capitalization of the pharmaceutical equals 1.13 billion leva.   Read the full article here in Bulgarian.

  • December 22, 2020

    Engr. Biser Georgiev, Executive Director: With a market cap of over BGN 1 billion Tchaikapharma remains the most expensive public company

    We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficult time, we could assure that the Bulgarian population had access to reliable and affordable medical prevention and early COVID-19 treatment with hydroxychloroquine. At the […]

  • October 5, 2020

    Prof. Dr. Rasho Rashkov: Rheumatic patients are more protected than COVID-19 … especially those who take hydroxychloroquine

    Patients with rheumatic disease are less likely to suffer from coronavirus, especially those taking hydroxychloroquine. That is why their therapy should not be interrupted during the pandemic, says rheumatologist Prof. Rasho Rashkov and clarifies that he and his colleagues have many years of experience in the treatment with hydroxychloroquine, as well as treatment of some […]

  • October 3, 2020

    Tchaikapharma remains the most expensive company

    Tchaikapharma High Quality Medicines Inc. remains the most expensive Bulgarian company on the Bulgarian Stock Exchange. After the market capitalization of the pharmaceutical company exceeded BGN 1 billion at the end of June, in July, August and September it added more value to its stock market valuation. The full article is available here in Bulgarian.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. ...
  9. 31
  10. Next
Copyright © 2010-2021 Tchaikapharma Inc.
  • Contact Us